Relationship between seroresponse to Epstein-Barr virus and survival in patients with lymphoid malignancies.

被引：0
|
作者：
Domingo-Domenech, E
Middeldorp, J
Gonzalez-Barca, E
Benavente, Y
Romagosa, V
Font, R
de Sevilla, AF
Meijer, CJ
de Sanjose, S
机构：
[1] Hosp Llobregat, Hosp Univ Bellvitge, Barcelona, Spain
[2] Hosp Llobregat, Inst Catala Oncol, Barcelona, Spain
[3] Vrije Univ Amsterdam, Univ Hosp, Amsterdam, Netherlands
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4688.4688
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4688
引用
收藏
页码：252B / 252B
页数：1
相关论文
共 50 条
  • [21] The Microenvironment in Epstein-Barr Virus-Associated Malignancies
    Tan, Geok Wee
    Visser, Lydia
    Tan, Lu Ping
    van den Berg, Anke
    Diepstra, Arjan
    PATHOGENS, 2018, 7 (02)
  • [22] Immune escape by Epstein-Barr virus associated malignancies
    Muenz, Christian
    Moormann, Ann
    SEMINARS IN CANCER BIOLOGY, 2008, 18 (06) : 381 - 387
  • [23] IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    Long, Heather M.
    Parsonage, Gregory
    Fox, Christopher P.
    Lee, Steven P.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (04) : 221 - 228
  • [24] Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
    Xu, Miao
    Zhang, Wei-Long
    Zhu, Qing
    Yao, You-yuan
    Feng, Qi-Sheng
    Zhang, Zhe
    Peng, Rou-Jun
    Jia, Wei-Hua
    He, Gui-Ping
    Feng, Lin
    Zeng, Zhao-Lei
    Luo, Bing
    Xu, Rui-Hua
    Zeng, Mu-Sheng
    Zhao, Wei-Li
    Chen, Sai-Juan
    Zeng, Yi-Xin
    Jiao, Yuchen
    THERANOSTICS, 2019, 9 (04): : 1115 - 1124
  • [25] Relationship between Epstein-Barr Virus (EBV) Infection and Viral Load in Immunosuppressive Patients
    Colak, Meryem
    Kocak, Aylin Altay
    Dalgic, Buket
    Ozkurt, Zubeyde Nur
    Fidan, Isil
    Ozkan, Secil
    Pinar, Ahmet
    Bozdayi, Gulendam
    ISTANBUL MEDICAL JOURNAL, 2018, 19 (01): : 7 - 13
  • [26] Epstein-Barr Virus: in Search of a Causal or a Casual Relationship Between the Virus and the Disease?
    Dardiotis, Efthymios
    Bogdanos, Dimitrios P.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2018, 20 (02): : 111 - 113
  • [27] A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
    Perrine, Susan R.
    Hermine, Olivier
    Small, Trudy
    Suarez, Felipe
    O'Reilly, Richard
    Boulad, Farid
    Fingeroth, Joyce
    Askin, Melissa
    Levy, Arthur
    Mentzer, Steven J.
    Di Nicola, Massimo
    Gianni, Alessandro M.
    Klein, Christoph
    Horwitz, Steven
    Faller, Douglas V.
    BLOOD, 2007, 109 (06) : 2571 - 2578
  • [28] Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies
    Lei, KIK
    Chan, LYS
    Chan, WY
    Johnson, PJ
    Lo, YMD
    CIRCULATING NUCLEIC ACIDS IN PLASMA OR SERUM II, 2001, 945 : 80 - 83
  • [29] A Phase I/II study of Arginine Butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
    Perrine, SP
    Hermine, O
    Mentzer, SJ
    Small, TN
    Horwitz, SM
    Fingeroth, J
    Boulad, F
    Di Nicola, M
    Klein, C
    O'Reilly, R
    Levy, A
    Faller, DV
    BLOOD, 2004, 104 (11) : 176A - 176A
  • [30] Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies
    Lei, KIK
    Chan, LYS
    Chan, WY
    Johnson, PJ
    Lo, YMD
    CLINICAL CHEMISTRY, 2001, 47 (02) : 366 - 366
12345